Dyadic International Inc, DE

DYAINASDAQ · USD
0.29USD0.00 (-7.66%)
132

Dyadic International Inc, DE (DYAI) Expected Move

DYAI expected move through Dec 18, 2026 is 1,689.7%, with 26 days to expiration. The implied range is -$4.61 to $5.19, based on the previous trading day's options prices.

Read more

Tracking the DYAI expected move helps you see how far Dyadic International Inc, DE's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Dyadic International Inc, DE's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the DYAI expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For DYAI, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The DYAI expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Dyadic International Inc, DE is unlikely to go.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the DYAI expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Dyadic International Inc, DE expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about DYAI.

DYAI Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Dec 18, 202626$4.901,689.7%$5.19-$4.61
Jan 15, 202754$5.351,844.8%$5.64-$5.06
Feb 19, 202789$4.651,603.4%$4.94-$4.36
May 21, 2027180$5.351,844.8%$5.64-$5.06

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →